Berner Kantonalbank AG (0QM2)
London Exchange · UK · prices in GBP · close of 23 Oct 2026
Key indicators
| Last close | GBP 428.00 |
|---|---|
| 52-week range | 258.50 – 429.00 |
| Return, 1 month / 3 months | +5.2% / +11.6% |
| Return, 1 year / 3 years | +64.3% / +81.2% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 19.1% |
| Worst drawdown (1 year) | -17.2% |
| Average daily value traded | 0.13M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Berner Kantonalbank is a Swiss cantonal bank based in Bern that serves private individuals, small and medium-sized businesses and institutional clients. It offers savings and current accounts, mortgages, consumer credit, corporate lending, payment services and wealth management, along with investment advice and pension products. The bank also supports local companies with trade finance and business banking services, and it operates through a network of branches across the canton of Bern.
Berner Kantonalbank AG trades under the code 0QM2 on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Berner Kantonalbank AG (0QM2) trades on the London Exchange in UK. It last closed at GBP 428.00 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 321 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 64.3% and over the last three months it rose 11.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.8% | ||
| From 52-week high | 0.0% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.6% | ||
| 6-month return | 7.7% | ||
| 12-month return, skipping the last month | 56.3% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.2% | ||
| Liquidity | 33 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.13M GBP | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.5% |
|---|---|
| 1 month | +5.2% |
| 3 months | +11.6% |
| 6 months | +7.7% |
| 1 year | +64.3% |
| 3 years | +81.2% |
| 5 years | +102.8% |
Signals
| 50-day / 200-day average | 403.91 / 379.53 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.13 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 May 2026 | GBX 0.1080 |
| 15 May 2025 | GBX 0.1040 |
| 23 May 2024 | GBX 0.1000 |
| 19 May 2023 | GBX 0.0960 |
| 19 May 2022 | GBX 0.0920 |
| 20 May 2021 | GBX 0.0880 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.